Applications for Cellular Dynamics International‘s Innovative Neuroscience Research grant program are now being accepted, the organization announced recently. According to its website, the company is awarding companies a limited number of free…
Propeller Health announced recently that its digital solution for asthma and COPD will be available to members of Express Scripts, a company that provides integrated pharmacy benefit management services. “With…
Due to high Cologuard demand and a growing workforce, Exact Sciences announced recently it is building an additional facility at 650 Forward Dr. “Doctors and patients are increasingly choosing the convenience of…
Phoenix announced today it raised $12 million in funding to support its next stage of growth and shortened its name from Phoenix Nuclear Labs. According to a release, Deerfield Management Company…
Lucigen is licensing Epicentre’s entire product portfolio from Illumina, the company announced recently. According to a release, Lucigen now has exclusive rights to manufacture and sell Epicentre products through its worldwide…
Cellectar Biosciences has extended its collaboration with Pierre Fabre, a French pharmaceutical company, the company announced today. “The extension of our research agreement with Pierre Fabre allows us to further…
The U.S. Patent and Trademark Office has awarded Lucigen a patent for its pJAZZ BigEasy System, the company announced recently. According to a release, the pJAZZ system offers the unique ability…
The U.S. Patent and Trademark Office awarded SHINE Medical Technologies a patent that relates to producing medical isotopes, the company announced recently. “This patent protects our technology in America, which…
Cellular Dynamics International (CDI) and Nanion Technologies, a leading provider of instrumentation for ion channel drug discovery and screening, announced they have entered into a joint marketing agreement. According to a…
Cellectar Biosciences announced today it has entered into a strategic collaboration with Onconova Therapeutics, a biopharmaceutical company, to develop new phospholipid drug conjugates (PDC). According to a release, the Newtown,…
